Oct. 8 (UPI) --The most common curable sexually transmitted disease isn't as effectively treated with the recommended single dose of medication compared with a more frequent regimen, according to a ...
patients managing their health at home, today announced the automation of multi-dose prescription fulfillment enabled through the company’s patent-pending pharmacy consumable called Pharmacy Auto Load ...
Cemsidomide demonstrated a 50% ORR at 100 μg, with one patient achieving a complete response and no detectable disease. The phase 1 study's dose-escalation phase is complete, and the 100 μg dose is ...
The following reader question came in response to the column “Critical Guidance for Complying With Anesthesia Infection Control Rules,” which features insight from Clifford Gevirtz, MD, an ...
Thanksgiving is typically an opportunity for families and friends to gather, but the COVID-19 pandemic has significantly altered those plans. The hope is that a successful vaccine will make it ...
GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of the newest addition to its innovative ...
RB042 Phase 1 trial advances into multiple ascending dose study cohorts, demonstrating safety and tolerability to date.Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results